Presentation is loading. Please wait.

Presentation is loading. Please wait.

Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma  Jerone M.H Hendriks, MD, Paul E.Y Van Schil,

Published byEija Laura Heino Modified over 5 years ago

Similar presentations

Presentation on theme: "Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma  Jerone M.H Hendriks, MD, Paul E.Y Van Schil,"— Presentation transcript:

1 Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma  Jerone M.H Hendriks, MD, Paul E.Y Van Schil, PhD, Gert De Boeck, Patrick R.M Lauwers, MD, Allan A.T Van Oosterom, PhD, Erik A.E Van Marck, PhD, Erik J.M Eyskens, PhD  The Annals of Thoracic Surgery  Volume 66, Issue 5, Pages (November 1998) DOI: /S (98)

2 Fig 1 Melphalan levels of venous effluent after isolated left lung perfusion with 0.5 mg and 1.0 mg of MN for 25 minutes and washout with BHE for 5 minutes. BHE: buffered hetastarch; MN: melphalan. The Annals of Thoracic Surgery  , DOI: ( /S (98) )

Download ppt "Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma  Jerone M.H Hendriks, MD, Paul E.Y Van Schil,"

Similar presentations

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,
Aprotinin improves pulmonary function during reperfusion in an isolated lung model  Menen A Mathias, MD, Curtis G Tribble, MD, Jeffrey F Dietz, BS, Richard.

Aprotinin improves pulmonary function during reperfusion in an isolated lung model  Menen A Mathias, MD, Curtis G Tribble, MD, Jeffrey F Dietz, BS, Richard.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Keith B Allen, MD, Carl J Shaar, PhD  The Annals of Thoracic Surgery 

Keith B Allen, MD, Carl J Shaar, PhD  The Annals of Thoracic Surgery 
Marianne G. De Maeseneer, MD, PhD, Chantal P

Marianne G. De Maeseneer, MD, PhD, Chantal P
A Scimitar Syndrome Variant: Anomalous Systemic Arterial Supply to the Right Lung With Normal Pulmonary Venous Return  Luis Gorospe, MD, Amparo Esteban-Peris,

A Scimitar Syndrome Variant: Anomalous Systemic Arterial Supply to the Right Lung With Normal Pulmonary Venous Return  Luis Gorospe, MD, Amparo Esteban-Peris,
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Real-Time Computed Tomography Highlights Pulmonary Parenchymal Evolution During Ex Vivo Lung Reconditioning  Edouard Sage, MD, PhD, Julien De Wolf, MD,

Real-Time Computed Tomography Highlights Pulmonary Parenchymal Evolution During Ex Vivo Lung Reconditioning  Edouard Sage, MD, PhD, Julien De Wolf, MD,
Completion pneumonectomy: analysis of operative mortality and survival

Completion pneumonectomy: analysis of operative mortality and survival
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Andranik Petrosyan, MD, Patrice Bergeron, MD 

Andranik Petrosyan, MD, Patrice Bergeron, MD 
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Pablo G. Sanchez, MD, PhD, Keshava Rajagopal, MD, PhD, Si M

Pablo G. Sanchez, MD, PhD, Keshava Rajagopal, MD, PhD, Si M
A Systematic Review of Pulmonary Embolism in Patients With Lung Cancer

A Systematic Review of Pulmonary Embolism in Patients With Lung Cancer
Bart P. Van Putte, MD, PhD, Tim Smith, MD, PhD, Thom L

Bart P. Van Putte, MD, PhD, Tim Smith, MD, PhD, Thom L
Boudewijn L. Reichmann, MD, Jorinde H. H. van Laanen, MD, Jean-Paul P

Boudewijn L. Reichmann, MD, Jorinde H. H. van Laanen, MD, Jean-Paul P
Postoperative Pneumonia After Major Pulmonary Resections: An Unsolved Problem in Thoracic Surgery  Dana M. Radu, MD, Françoise Jauréguy, Pharm D, Agathe.

Postoperative Pneumonia After Major Pulmonary Resections: An Unsolved Problem in Thoracic Surgery  Dana M. Radu, MD, Françoise Jauréguy, Pharm D, Agathe.
Pericardial synovial sarcoma: 14-year survival with multimodality therapy  Gerry Van der Mieren, MD, Stefan Willems, MD, Raf Sciot, MD, PhD, Herlinde Dumez,

Pericardial synovial sarcoma: 14-year survival with multimodality therapy  Gerry Van der Mieren, MD, Stefan Willems, MD, Raf Sciot, MD, PhD, Herlinde Dumez,

Similar presentations

Ads by Google